Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
159 studies found for:    Open Studies | "Mild Cognitive Impairment"
Show Display Options
Rank Status Study
21 Recruiting Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Patients With Mild Cognitive Impairments
Condition: Mild Cognitive Impairment, So Stated
Interventions: Device: Stimulation;   Device: SHAM
22 Recruiting Effects of Brain Stimulation During a Daytime Nap on Memory Consolidation in Patients With Mild Cognitive Impairment
Condition: Mild Cognitive Impairment, So Stated
Interventions: Device: SHAM stimulation;   Device: 0,75 Hz stimulation
23 Not yet recruiting The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment
Condition: Mild Cognitive Impairment (MCI)
Interventions: Drug: Methylphenidate;   Drug: Placebo
24 Unknown  Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment
Conditions: Alzheimer's Disease;   Amnestic Mild Cognitive Impairment
Intervention: Drug: Posiphen® tartrate capsules
25 Recruiting Influence of tDCS on Cortical Plasticity in Patients With Mild Cognitive Impairment (MCI)
Condition: Patients With Mild Cognitive Impairment
Interventions: Device: transcranial direct current stimulation;   Device: sham stimulation
26 Recruiting Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment
Condition: MILD COGNITIVE IMPAIRMENT
Intervention: Procedure: Lumbar puncture
27 Recruiting Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Intervention: Device: Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unit
28 Recruiting Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment
Condition: Mild Cognitive Impairment
Interventions: Other: Medium Chain Triglyceride Oil;   Other: Placebo Oil
29 Recruiting Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease
Conditions: Cerebrovascular Disease;   Mild Cognitive Impairment
Intervention: Behavioral: Heart Health Intervention
30 Unknown  Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to Dementia
Condition: Mild Cognitive Impairment
Intervention:
31 Not yet recruiting A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
Conditions: Overactive Bladder;   Mild Cognitive Impairment
Interventions: Drug: fesoterodine 4mg;   Drug: Oxybutynin;   Drug: placebo;   Drug: fesoterodine 8mg
32 Recruiting Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI)
Condition: Mild Cognitive Impairment
Interventions: Behavioral: caloric restriction;   Behavioral: omega-3 supplementation;   Behavioral: resveratrol supplementation;   Behavioral: Placebo;   Behavioral: 2nd step: intervention + physical / cognitive training;   Behavioral: 2nd step: intervention + control
33 Recruiting Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment
Condition: Mild Cognitive Impairment
Intervention: Other: Phosphatidylserine
34 Recruiting The Effect of a 36-week Tablet-based Intervention on Multiple Domains in Older Adults With Mild Cognitive Impairment
Condition: Mild Cognitive Impairment
Interventions: Other: Kodro+;   Other: Kodro+D
35 Recruiting Hyperbaric Oxygen Therapy for Mild Cognitive Impairment
Condition: Mild Cognitive Impairment and Vascular Subcortical Ischemia
Intervention: Device: Hyperbaric oxygen therapy
36 Not yet recruiting AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease
Condition: Mild Cognitive Impairment Due to Alzheimer's Disease
Interventions: Drug: Pioglitazone;   Drug: Placebo
37 Recruiting Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset
Condition: Mild Cognitive Impairment Due to Alzheimer's Disease
Interventions: Drug: Pioglitazone;   Drug: Pioglitazone placebo
38 Unknown  Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study
Conditions: Mild Cognitive Impairment;   Cognitive Disorders
Intervention: Behavioral: 5-month aerobic exercise intervention
39 Recruiting Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD
Conditions: Mild Cognitive Impairment;   Alzheimer Disease
Interventions: Drug: Allopregnanolone injection (intravenous solution);   Drug: Placebo injection (intravenous solution)
40 Unknown  Driving Ability Among People With Mild Cognitive Impairment
Condition: Mild Cognitive Impairment
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years